Wellington Management Group’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZEAL
FCM
AIC
Wellington Management Group's ZEAL Position: Q1 2022 in Review
Wellington Management Group sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q1 2022, closing a stake of 70,418 shares — an estimated $1.5M sold.
Wellington Management Group first reported a position in ZEAL in Q3 2017 and held it in 18 quarters. The position peaked at $49.4M in Q1 2020. 10 funds tracked by Wall St. Rank hold ZEAL as of Q1 2022.
- Wellington Management Group reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q1 2022 after selling out during the quarter.
- Wellington Management Group sold 70,418 Zealand Pharma A/S American Depositary Shares shares in Q1 2022, an estimated $1.5M.
- Wellington Management Group first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 18 quarters.
- Wellington Management Group's Zealand Pharma A/S American Depositary Shares position peaked at $49.4M in Q1 2020.
- 10 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q1 2022.
Based on Wellington Management Group's 13F filing for Q1 2022, filed 16 May 2022.